This medical app calculates radiotherapy dose equivalents using the linear-quadratic model. It allows users to select specific organs at risk or define their own alpha/beta ratios for research purposes.
3.0
October 27, 2026
More than 10 years after its last update and over 25,000 downloads, iLQ is back! iLQ 3.0 is a complete rewrite: • Optimized for iPhone Duo, with inputs and result on either side of the fold • Now also available on Mac with Apple silicon • New native interface, faster and clearer • Results update as you type • Clearer warnings for model limits and organ dose constraints • Enter doses with a decimal comma or point • Linear-quadratic model formulas shown in the app • Dark mode • Available in 15 languages
MoreiLQ is a medical application designed to calculate radiotherapy dose equivalents. It utilizes the linear-quadratic model for its calculations and is intended solely for research purposes, not clinical application.
No, iLQ is strictly for research use only and cannot be applied in clinical practice. Its purpose is to aid in the investigation and understanding of radiotherapy dose equivalencies.
The application allows users to select various organs at risk for their calculations. These include options such as bone marrow, heart, lungs, and liver, among others.
Yes, iLQ provides the flexibility to choose a specific organ at risk or to define your own alpha/beta ratio for personalized research calculations.
iLQ has a rating of 3.5 stars based on 2 user reviews. This indicates a mixed but generally positive reception from its limited user base.
Based on the provided data, iLQ is supported on iPhone, iPad, and iPod devices. Information regarding Android compatibility is not available.
The latest version of iLQ is 2.0.1, which was last updated on November 15, 2015. This suggests infrequent updates for the application.
iLQ has an age rating of 17+, meaning it is intended for mature audiences. This is likely due to the complex medical subject matter it addresses.
